About Us

color_break_300x7

Empowering the new era of drug development

 

At TeraPore, we operate on the cutting edge of bioprocessing innovation. As the biopharma industry strives to fulfill the promise of bold scientific discoveries that treat and cure diseases and improve patients’ lives, our new generation bioseparation solutions are poised to help make their vision a reality. By harnessing our proprietary nanofiltration membrane technology, we aim to support biopharma companies in solving the most complex manufacturing challenges, enabling them to deliver advanced therapeutics and novel biologic drugs faster and more efficiently. 

TeraPore is an agile, entrepreneurial organization that is well positioned to fill the innovation gap in bioseparation technology.

We have assembled a leadership team and scientific advisory board comprised of foremost experts in material science, engineering, and bioprocessing, who have decades of experience in the design and commercialization of bioseparation products. We are uniquely qualified and singularly focused on making an impact on bioprocessing innovation and novel drug development for decades to come.

Meet Our Team

Seperator
President & CEO
Chief Commercial Officer
Jae Cho, Ph.D.
Jae Cho, Ph.D.
Jack Wilson
Jack Wilson
Sylvie Chavanne
Sylvie Chavanne
Kyle Johnson
Kyle Johnson
Lida Baghernejad, PhD
Lida Baghernejad, Ph.D.
Tim Simpson
Tim Simpson
Stephanie Meyer
Stephanie Meyer
Nashea Awais
Nashea Awais
Oliver Palmer
Oliver Palmer
Ajia Sugahara
Ajia Sugahara
Brian Fang
Brian Fang
Cecelia Rivera
Cecelia Rivera
Daniel Rusu
Daniel Rusu
David Shis Ph.D.
David Shis Ph.D.
Madhavi Sivan
Madhavi Sivan
Adelaide-Pope
Adelaide Pope

Board of Directors

color_break_300x7

Advisory Board

color_break_300x7
Mark Hurwitz, PhD
Mark Hurwitz, Ph.D.
Adviser
Roberta McKee, PhD
Roberta McKee, Ph.D.
Adviser
John Grant, PhD
John Grant, Ph.D.
Adviser
Ray Colton, PhD
Ray Colton, Ph.D.
Adviser
Neil Schauer, PhD
Neil Schauer, Ph.D.
Adviser
Ulrich Wiesner, PhD
Ulrich Wiesner, Ph.D.
Adviser

Our Investors

Seperator
Anzu
RA Capital
Artiman